These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24000165)

  • 1. UBE2QL1 is disrupted by a constitutional translocation associated with renal tumor predisposition and is a novel candidate renal tumor suppressor gene.
    Wake NC; Ricketts CJ; Morris MR; Prigmore E; Gribble SM; Skytte AB; Brown M; Clarke N; Banks RE; Hodgson S; Turnell AS; Maher ER; Woodward ER
    Hum Mutat; 2013 Dec; 34(12):1650-61. PubMed ID: 24000165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
    Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
    Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumor suppressor gene FBXW7 is disrupted by a constitutional t(3;4)(q21;q31) in a patient with renal cell cancer.
    Kuiper RP; Vreede L; Venkatachalam R; Ricketts C; Kamping E; Verwiel E; Govaerts L; Debiec-Rychter M; Lerut E; van Erp F; Hoogerbrugge N; van Kempen L; Schoenmakers EF; Bonne A; Maher ER; Geurts van Kessel A
    Cancer Genet Cytogenet; 2009 Dec; 195(2):105-11. PubMed ID: 19963109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of renal cell carcinoma-associated constitutional chromosome abnormalities by genome sequencing.
    Smith PS; Whitworth J; West H; Cook J; Gardiner C; Lim DHK; Morrison PJ; Hislop RG; Murray E; ; Tischkowitz M; Warren AY; Woodward ER; Maher ER
    Genes Chromosomes Cancer; 2020 Jun; 59(6):333-347. PubMed ID: 31943436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma.
    Clifford SC; Astuti D; Hooper L; Maxwell PH; Ratcliffe PJ; Maher ER
    Oncogene; 2001 Aug; 20(36):5067-74. PubMed ID: 11526493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
    Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FBXW7 overexpression suppresses renal cancer cell proliferation and induces apoptosis.
    Fu Y; Lin Y; Yang Z; Yang G; Li G; Liu Y; Tan X; Huang Y; Wu X; Wang Y; Xiong H; Zhang M; Fang L; Ge Y; Zeng J; Cai Y; Bai J; Wu S
    Med Oncol; 2015 Aug; 32(8):215. PubMed ID: 26163148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetic locus NRC-1 within chromosome 3p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment, and VHL mutation.
    Lovell M; Lott ST; Wong P; El-Naggar A; Tucker S; Killary AM
    Cancer Res; 1999 May; 59(9):2182-9. PubMed ID: 10232606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial clear cell renal cell carcinoma (FCRC): clinical features and mutation analysis of the VHL, MET, and CUL2 candidate genes.
    Woodward ER; Clifford SC; Astuti D; Affara NA; Maher ER
    J Med Genet; 2000 May; 37(5):348-53. PubMed ID: 10807693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.
    Na X; Wu G; Ryan CK; Schoen SR; di'Santagnese PA; Messing EM
    J Urol; 2003 Aug; 170(2 Pt 1):588-92. PubMed ID: 12853836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1).
    Meléndez B; Rodríguez-Perales S; Martínez-Delgado B; Otero I; Robledo M; Martínez-Ramírez A; Ruiz-Llorente S; Urioste M; Cigudosa JC; Benítez J
    Hum Genet; 2003 Feb; 112(2):178-85. PubMed ID: 12522559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
    Zbar B
    Cancer Surv; 1995; 25():219-32. PubMed ID: 8718521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A constitutional balanced t(3;8)(p14;q24.1) translocation results in disruption of the TRC8 gene and predisposition to clear cell renal cell carcinoma.
    Poland KS; Azim M; Folsom M; Goldfarb R; Naeem R; Korch C; Drabkin HA; Gemmill RM; Plon SE
    Genes Chromosomes Cancer; 2007 Sep; 46(9):805-12. PubMed ID: 17539022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of a novel constitutional translocation t(1q;3q) with familial renal cell carcinoma.
    Kanayama H; Lui WO; Takahashi M; Naroda T; Kedra D; Wong FK; Kuroki Y; Nakahori Y; Larsson C; Kagawa S; Teh BT
    J Med Genet; 2001 Mar; 38(3):165-70. PubMed ID: 11238683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutional translocation breakpoint mapping by genome-wide paired-end sequencing identifies HACE1 as a putative Wilms tumour susceptibility gene.
    Slade I; Stephens P; Douglas J; Barker K; Stebbings L; Abbaszadeh F; Pritchard-Jones K; ; Cole R; Pizer B; Stiller C; Vujanic G; Scott RH; Stratton MR; Rahman N
    J Med Genet; 2010 May; 47(5):342-7. PubMed ID: 19948536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. F-box and WD repeat domain-containing-7 (Fbxw7) protein targets endoplasmic reticulum-anchored osteogenic and chondrogenic transcriptional factors for degradation.
    Yumimoto K; Matsumoto M; Onoyama I; Imaizumi K; Nakayama KI
    J Biol Chem; 2013 Oct; 288(40):28488-502. PubMed ID: 23955342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FBXW7 is involved in the acquisition of the malignant phenotype in epithelial ovarian tumors.
    Kitade S; Onoyama I; Kobayashi H; Yagi H; Yoshida S; Kato M; Tsunematsu R; Asanoma K; Sonoda K; Wake N; Hata K; Nakayama KI; Kato K
    Cancer Sci; 2016 Oct; 107(10):1399-1405. PubMed ID: 27486687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney.
    Anglesio MS; Evdokimova V; Melnyk N; Zhang L; Fernandez CV; Grundy PE; Leach S; Marra MA; Brooks-Wilson AR; Penninger J; Sorensen PH
    Hum Mol Genet; 2004 Sep; 13(18):2061-74. PubMed ID: 15254018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a 3;6 translocation associated with renal cell carcinoma.
    Foster RE; Abdulrahman M; Morris MR; Prigmore E; Gribble S; Ng B; Gentle D; Ready S; Weston PM; Wiesener MS; Kishida T; Yao M; Davison V; Barbero JL; Chu C; Carter NP; Latif F; Maher ER
    Genes Chromosomes Cancer; 2007 Apr; 46(4):311-7. PubMed ID: 17205537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-suppressor Fbxw7 targets SIK2 for degradation to interfere with TORC2-AKT signaling in pancreatic cancer.
    Zhang MX; Wang H; Sun GP
    Cell Biol Int; 2020 Sep; 44(9):1900-1910. PubMed ID: 32437091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.